Search alternatives:
shape decrease » shape increases (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
shape decrease » shape increases (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
1881
Results of comparison experiments.
Published 2024“…Subsequently, the images are evenly partitioned into small patch blocks, serving as inputs to the enhanced Transformer model. …”
-
1882
Architecture of Swin Transformer Block.
Published 2024“…Subsequently, the images are evenly partitioned into small patch blocks, serving as inputs to the enhanced Transformer model. …”
-
1883
Disease distribution map of the GZDL-BD.
Published 2024“…Subsequently, the images are evenly partitioned into small patch blocks, serving as inputs to the enhanced Transformer model. …”
-
1884
Token merging module.
Published 2024“…Subsequently, the images are evenly partitioned into small patch blocks, serving as inputs to the enhanced Transformer model. …”
-
1885
Comparative results of the ablation experiments.
Published 2024“…Subsequently, the images are evenly partitioned into small patch blocks, serving as inputs to the enhanced Transformer model. …”
-
1886
-
1887
-
1888
-
1889
-
1890
-
1891
Data Sheet 1_Remarkable tumor response to Iruplinalkib in a 14-year-old girl with ALK-positive advanced metastatic non–small-cell lung cancer: a case report.pdf
Published 2025“…<p>Targeted therapies for anaplastic lymphoma kinase (ALK) mutations in non-small cell lung cancer (NSCLC) generally extend survival and alleviate symptoms. …”
-
1892
Data Sheet 1_Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic N...
Published 2025“…Background<p>Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-based combination therapy modalities for patients with EGFR-mutated stage IV non-small cell lung cancer (NSCLC) are being investigated. …”
-
1893
-
1894
-
1895
-
1896
-
1897
Seasonal variability in the secondary metabolite content of <i>Commelina</i> species.
Published 2024Subjects: -
1898
Altitudinal variability in the secondary metabolite content of <i>Commelina</i> species.
Published 2024Subjects: -
1899
-
1900